Option Extension. The Company will amend the post-termination exercise periods set forth in the agreements reflecting the Outstanding Options such that Executive shall have until the earlier of (i) January 15, 2022 and (ii) the last day of the applicable ten-year term of the applicable Outstanding Option to exercise the Outstanding Options.
Appears in 2 contracts
Sources: Separation and Release Agreement, Separation and Release Agreement (Onconova Therapeutics, Inc.)